Domicile
Reels
Groupes
Pages
Plus
Groupes Pages Evènements Blogs Offres Emplois Courses Forums Film Jeux
Se connecter S’enregistrer
Mode nuit
Infectious-Disease and Endocrine Testing Drive CLIA Adoption
Chemiluminescence immunoassay technology is becoming an essential part of clinical testing because it can detect low concentrations of biomarkers with speed and accuracy. Its use in infectious-disease and endocrine testing is creating strong demand for analyzers, kits, and reagents. The Chemiluminescence Immunoassay Market is projected to grow from USD 6.56 billion in 2024 to USD 11.22 billion...
0 Commentaires ·0 Parts ·188 Vue ·0 Aperçu
Connectez-vous pour aimer, partager et commenter!